Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical metformin 30% vs azelaic acid 20% for melasma
IRCT20120215009014N505Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in melasma comparing Metformin cream 30% with Azelaic acid cream 20% (2 arms). Started Apr 2024; status: completed.
02
Drugs
metforminAzelaic acid
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20120215009014N505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N505.